Membranous glomerulonephropathy associated with hepatitis B virus infection

Hong Kong Journal of Paediatrics

Volumn 13, Issue 1, 2008, Pages

  Liu, X R ^a   Shen, Y ^a   Yang, Y H ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Glomerulonephropathy; Hepatitis B virus; Membranous

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; DIURETIC AGENT; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE;

ALOPECIA; ANTIGEN ANTIBODY COMPLEX; BLOOD DYSCRASIA; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INHIBITION; DRUG SAFETY; FEVER; GENE FREQUENCY; GENETIC PREDISPOSITION; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALAISE; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; MYALGIA; PROTEINURIA; REVIEW; SEROLOGY; VIRUS CARRIER;

EID: 38949168857     PISSN: 10139923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971;2:234-7.
2. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211.
3. Chinese MedicalAssociation 1989. Symposium on HBV-Associated Glomerulonephropathy. Chin J Med 1990;29:358-65.
4. Yoshikawa N, Ito H, Yamada Y, et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 1985;23:28-34.
5. Nagy J, Bajtai G, Brasch H, et al. The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clin Nephrol 1979;12:109-16.
6. Zhang Y, Fang L, Ma X. Hepatitis B virus infection and pathogenesis of glomerulonephritis. Zhonghua Bing Li Xue Za Zhi 1995;24:341-4.
7. Lin CY, Lin CC, Chang GJ, King CC. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy. Nephron 1997;76:176-85.
8. Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI. Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med 1974;81:448-51.
9. Gregorek H, Jung H, Ulanowicz G, Madalinski K. Immune complexes in sera of children with HBV-mediated glomerulonephritis. Arch Immunol Ther Exp (Warsz) 1986;34:73-83.
10. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663-76.
11. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995;47:225-30.
12. Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 1983;58:488-96.
13. Couser WG, Abrass CK. Pathogenesis of membranous nephropathy. Annu Rev Med 1988;39:517-30.
14. Agodoa LY, Gauthier VJ, Mannik M. Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol 1985;134:880-4.
15. He XY, Fang LJ, Zhang YE, Sheng FY, Zhang XR, Guo MY. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998;12:117-20.
16. Zhou SD, Zhang YE, Fang LJ et al. The study of the significance of the appearance of HbcAg in glomerulonephritis. Chin J Nephrol 1995;11:104-6.
17. Bhimma R, Hammond MG, Coovadia HM, Adhikari M, Connolly CA. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int 2002;61:1510-5.
18. Vaughan RW, Zurowska A, Moszkowska G, Kondeatis E, Clark AG. HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy. Tissue Antigens 1998;52:130-4.
19. Abdool Karim SS, Thejpal R, Coovadia HM. Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol 1991;20:495-503.
20. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8:11-4.
21. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-7.
22. Lai FM, Tam JS, Li PK, Lai KN. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 1989;414:279-84.
23. Fabrizi F, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther 2006;24:781-8.
24. Lai CL, Ching CK, Tung AK, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 1997;25:241-4.
25. Leung NW, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001;33:1527-32.
26. Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998;27:1670-7.
27. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 2003;88:446-9.
28. Ishikawa T, Kakumu S, Yoshioka K, et al. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B. Liver 1993;13:95-101.
29. Boni C, Bertoletti A, Penna A, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998;102:968-75.
30. Kew MC. Protective efficacy of hepatitis B vaccination. Lancet 1995;345:1065-6.
31. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997;99:351-3.
32. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
33. The people of South Africa, Population census 1996. Statistics South Aferica 1998:4-22.